Evidence map›Paper›PMID 40506669›Full record

ArticleEJNMMI research2025

A strategy for the automatic diagnostic pipeline towards feature-based models: a primer with pleural invasion prediction from preoperative PET/CT images.

Xiangxing Kong, Annan Zhang, Xin Zhou, Meixin Zhao, Jiayue Liu, Xinliang Zhang, Weifang Zhang, Xiangxi Meng, Nan Li, Zhi Yang

Abstract read
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiangxing Kong *Institution of Medical Technology, Peking University Health Science Center, Beijing, 100191, China.
Annan Zhang *Department of Nuclear Medicine, Peking University Third Hospital, Beijing, 100191, China.
Xin ZhouKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd., Haidian District, Beijing, 100142, China.
Meixin ZhaoDepartment of Nuclear Medicine, Peking University Third Hospital, Beijing, 100191, China.
Jiayue LiuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd., Haidian District, Beijing, 100142, China.
Xinliang ZhangInstitution of Medical Technology, Peking University Health Science Center, Beijing, 100191, China.
Weifang ZhangDepartment of Nuclear Medicine, Peking University Third Hospital, Beijing, 100191, China.
Xiangxi MengKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd., Haidian District, Beijing, 100142, China. mengxiangxi@pku.edu.cn.
Nan LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd., Haidian District, Beijing, 100142, China. Rainbow6283@sina.com.
Zhi YangInstitution of Medical Technology, Peking University Health Science Center, Beijing, 100191, China. pekyz@163.com.ORCID http://orcid.org/0000-0003-2084-5193

Funding

Key Clinical Project of Peking University Third Hospital BYSYZD2024043National Key R&D Program of China 2022YFC2409405National Natural Science Foundation of China 82372001
6 · The paper itself

Abstract

backgroundThis study aims to explore the feasibility to automate the application process of nomograms in clinical medicine, demonstrated through the task of preoperative pleural invasion prediction in non-small cell lung cancer patients using PET/CT imaging.

resultsThe automatic pipeline involves multimodal segmentation, feature extraction, and model prediction. It is validated on a cohort of 1116 patients from two medical centers. The performance of the feature-based diagnostic model outperformed both the radiomics model and individual machine learning models. The segmentation models for CT and PET images achieved mean dice similarity coefficients of 0.85 and 0.89, respectively, and the segmented lung contours showed high consistency with the actual contours. The automatic diagnostic system achieved an accuracy of 0.87 in the internal test set and 0.82 in the external test set, demonstrating comparable overall diagnostic performance to the human-based diagnostic model. In comparative analysis, the automatic diagnostic system showed superior performance relative to other segmentation and diagnostic pipelines.

conclusionsThe proposed automatic diagnostic system provides an interpretable, automated solution for predicting pleural invasion in non-small cell lung cancer.

Indexed as

Deep learningNon-small cell lung cancerPleural invasionPredictive diagnostic modelingRadiomics

Identifiers

PMID40506669
PMCPMC12162436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.